LPAR1 and neoplasm: The H-scores for LPAR1 staining in the lymphatic metastatic lesions and recurrent lesions were noticeably higher than the primary tumor lesions (159.08 ± 27.23 vs 145.69 ± 29.45, P = 0.024; 165.25 ± 21.49 vs 145.69 ± 29.45, P = 0.031, respectively) (Table 3).